期刊文献+

拉米夫定片质量比较研究和评价 被引量:7

Quality Comparison of Different Lamivudine Tablets
下载PDF
导出
摘要 目的:对2个厂家的拉米夫定片进行质量比较研究,探讨其质量差异的原因,对其质量进行评价。方法:采用光纤药物溶出/释放度原位过程监测仪测定拉米夫定片溶出曲线,用高效液相色谱法测定拉米夫定片含量、有关物质,分析试验结果。结果:两家产品溶出行为有显著差异,有关物质量也有明显区别。结论:原料药质量和产品处方工艺不同是导致不同厂家生产拉米夫定片剂质量差异的关键因素。 Objective: To investigate the quality of differences lamivudine tablets and explore the reason of their differences for quality evaluation.Method: The dissolution procession of lamivudine tablets was determinated simultaneously with fiber-optic medicine dissolution/release rate process monitoring system.Stress studies were employed to obtain the degradation information of lamivudine tablets.Result: There were significant differences in dissolution procession as well as impurities between two lamivudine tablets.Conclusion: The bulk drug quality and production technology may lead to quality differences of lamivudine tablets.
出处 《药学与临床研究》 2011年第3期220-223,共4页 Pharmaceutical and Clinical Research
关键词 拉米夫定 溶出度 有关物质 比较研究 质量评价 Lamivudine Dissolution Impurities Comparative study Quality evaluation
  • 相关文献

参考文献5

二级参考文献53

共引文献1096

同被引文献35

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2吕卫红,方鹏飞.慢性乙型肝炎的抗病毒治疗进展[J].医药导报,2006,25(5):444-447. 被引量:13
  • 3曾军.拉米夫定片的制备及质量控制[J].海峡药学,2007,19(4):16-18. 被引量:2
  • 4毕殿洲.药剂学[M].4版.北京:人民卫生出版社,1999:378-379. 被引量:23
  • 5ICH steering committee. ICH harmonised tripartite guideline: Impurities in new drug products: Q3B (R2) [ EB/OL]. [ 2012- 01 - 09 ]. http://www, ich. org/ fileadmin/Public _ Web _ Site/ICH _ Products/Guide- lines/Quality/Q3B_R2/Step4/Q3B R2 Guideline. pdf. 被引量:1
  • 6ICH steering committee. ICH harmonised tripartite guideline: Impurities in new drug products: Q3 A (R2) [ EB/OL]. [ 2012- 01 - 09 ]. http://www, ich. org/ fileadmin/Public- Web _ Site/ICH _ Products/Guide- lines/Quality/Q3B_R2/Step4/Q3B R2 Guideline.pdf. 被引量:1
  • 7U. S. Department of health and human services (DHHS). Guidelines for the use of antiretroviral a- gents in HIV-l-infected adults and adolescents [ M ]. Washington, D. C. AIDS research advisory council office of DHHS ,January 10, 2000:8 - 9. 被引量:1
  • 8The British Pharmacopoeia Commission. The British Pharmacopoeia 2011 [ M ]. London: the Stationary Of- fice,2010:1270 - 1272. 被引量:1
  • 9European Directorate for the Quality of Medicine. The European Pharmacopoeia 7. 0 [ M ]. Strasbourg (France) : the Directorate for the Quality of Medicine of the Council of Europe,2011:2337 -2339. 被引量:1
  • 10WHO department of essential medicines and pharma- ceutical policies (EMP). The international pharmaco- poeia editiotertia 4th, the second supplement[ S ]. Ge- neva: WHO Press,2011 : lamivudine monograph. 被引量:1

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部